![]() ASLAN Pharmaceuticals ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market. | ![]() Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. | ![]() BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies. | |
Founding Date | Founding Date N/A | Founding Date 1994 | Founding Date 2010 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations SG HQ Collingwood, AU | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US | Locations Florham Park, US HQ |
Employees | Employees 35 | Employees 8174% decrease | Employees 4014% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 96.2 m | Valuation ($) 89.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) $12m (FY, 2023) | Revenue (est.) $114.2m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $12m (FY, 2023) | Gross profit $113.2m (FY, 2025) | Gross profit N/A |
Net income | Net income ($44.2m) (FY, 2023) | Net income ($3.1m) (FY, 2025) | Net income ($16.7m) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 100m | Total funding raised $ 171.1m | Total funding raised $ 36.1m |

Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
View company
BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.
View company